[Ethics in clinical trials designs and alternative methods].
作者信息
Saenz Carla, Luna Florencia, Salas Sofía P, Canario Julio Arturo, Chamorro Jackeline Bravo, Palacios Ricardo, Quiroz Estela, Saidón Patricia, Villela Bertha María
机构信息
Programa Regional de Bioética, Organización Panamericana de la Salud, Washington D.C., Estados Unidos de América.
Programa de Bioética, FLACSO Argentina, Buenos Aires, Argentina.
出版信息
Rev Panam Salud Publica. 2018 Jan;42. doi: 10.26633/RPSP.2018.38.
Abstract
摘要
相似文献
1
[Ethics in clinical trials designs and alternative methods].[临床试验设计中的伦理与替代方法]
Rev Panam Salud Publica. 2018 Jan;42. doi: 10.26633/RPSP.2018.38.
2
Limitations of randomized clinical trials. Proposed alternative designs.随机临床试验的局限性。提议的替代设计。
Clin Chem Lab Med. 2000 Dec;38(12):1217-23. doi: 10.1515/CCLM.2000.192.
3
The Real-World Ethics of Adaptive-Design Clinical Trials.适应性设计临床试验的真实世界伦理
Hastings Cent Rep. 2017 Nov;47(6):27-37. doi: 10.1002/hast.783.
4
A Unified Family of Covariate-Adjusted Response-Adaptive Designs Based on Efficiency and Ethics.基于效率与伦理的协变量调整响应自适应设计统一族
J Am Stat Assoc. 2015 Apr 22;110(509):357-367. doi: 10.1080/01621459.2014.903846.
5
Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.临床儿科精神药理学中的传统及替代研究设计与方法
J Am Acad Child Adolesc Psychiatry. 1996 Oct;35(10):1292-303. doi: 10.1097/00004583-199610000-00016.
6
Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?伦理学、数据依赖型设计与临床试验策略：是时候开始边做边学了吗？
Stat Methods Med Res. 2002 Oct;11(5):381-402. doi: 10.1191/0962280202sm298ra.
7
Some ethical issues in phase II trials in acute leukemia.急性白血病II期试验中的一些伦理问题。
Clin Adv Hematol Oncol. 2005 Dec;3(12):943-8.
8
[Experience in the global forum of bioethics in research. Challenges for the ethical review in Chile].[全球生物伦理研究论坛的经验。智利伦理审查面临的挑战]
Rev Med Chil. 2018 May;146(5):653-659. doi: 10.4067/s0034-98872018000500653.
9
Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches.基于模型的儿科试验替代研究设计评估。第一部分：频率论方法。
CPT Pharmacometrics Syst Pharmacol. 2016 Jun;5(6):305-12. doi: 10.1002/psp4.12083. Epub 2016 Jun 1.
10
Indications and requirements for the use of prerandomization.随机分组前的使用指征和要求。
J Clin Epidemiol. 2009 Apr;62(4):393-9. doi: 10.1016/j.jclinepi.2008.07.010. Epub 2008 Dec 3.
引用本文的文献
1
The global forum on bioethics in research meeting, "ethics of alternative clinical trial designs and methods in low- and middle-income country research": emerging themes and outputs.全球研究中的生物伦理学论坛会议，“在低收入和中等收入国家研究中的替代临床试验设计和方法的伦理学”：新兴主题和成果。
Trials. 2019 Dec 19;20(Suppl 2):701. doi: 10.1186/s13063-019-3840-3.
本文引用的文献
1
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).一种重组水疱性口炎病毒载体疫苗预防埃博拉病毒病的有效性和效果：几内亚环状疫苗接种、开放标签、整群随机试验（埃博拉到此为止！）的最终结果
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
2
Ethical Rationale for the Ebola "Ring Vaccination" Trial Design.埃博拉“环式疫苗接种”试验设计的伦理依据。
Am J Public Health. 2016 Mar;106(3):432-5. doi: 10.2105/AJPH.2015.302996. Epub 2016 Jan 21.
3
Evaluating novel therapies during the Ebola epidemic.在埃博拉疫情期间评估新型疗法。
JAMA. 2014 Oct 1;312(13):1299-300. doi: 10.1001/jama.2014.12867.
4
The Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials.《关于群组随机对照试验的伦理设计和实施的渥太华声明》。
PLoS Med. 2012;9(11):e1001346. doi: 10.1371/journal.pmed.1001346. Epub 2012 Nov 20.
5
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件